Explore every branch of pathology from surgical and molecular to digital and forensic. Comprehensive coverage of training requirements, career paths, salary expectations and research opportunities across all 18 subspecialties.
Subspecialties Covered
Detailed guidance for each branch
Fellowship & certification details
Emerging frontiers in every field
Surgical pathology, cytopathology, dermatopathology, neuropathology, renal pathology, ophthalmic pathology, pediatric pathology, GI & hepatopathology, breast pathology, bone & soft tissue pathology.
Hematopathology, clinical chemistry, medical microbiology, immunology, transfusion medicine.
Molecular pathology, digital pathology, forensic pathology.
Decision framework covering volume, patient contact, lifestyle, salary and technology factors.
All 18 subspecialties compared across fellowship length, salary, demand, research intensity and more.
Links to career guides, certification details, job boards and educational pathways.
The core tissue-based disciplines that form the backbone of diagnostic pathology. Anatomical pathologists examine cells and tissues under the microscope to diagnose disease, guide treatment and determine prognosis.
Surgical pathology is the examination of tissue specimens obtained from biopsies and surgical resections. It is the largest and most central pathology subspecialty, forming the core of most pathology residency training programmes worldwide. Surgical pathologists provide the definitive tissue diagnosis that guides patient management, from cancer staging to the assessment of inflammatory and infectious conditions.
A surgical pathologist's daily workflow includes grossing (macroscopic examination and sectioning of specimens), microscopic examination of stained tissue sections, intraoperative frozen section consultation, tumour staging and grading, and multidisciplinary team participation. The subspecialty demands strong visual pattern recognition, systematic diagnostic approaches and clear, clinically actionable reporting.
Haematoxylin and eosin (H&E) staining remains the foundation, supplemented by immunohistochemistry (IHC), special stains (PAS, trichrome, reticulin), and increasingly by molecular ancillary testing. Whole slide imaging is transforming how surgical pathologists review cases, enabling remote consultation and AI-assisted diagnosis.
Surgical pathology forms the core of anatomical pathology residency training in both the US (AP or AP/CP track) and the UK (histopathology training programme). Additional fellowship training of 1–2 years is available for those seeking subspecialty expertise in areas such as GI, breast, or genitourinary pathology.
Surgical pathology is the most common pathology subspecialty with the highest case volume. It offers diverse practice settings from academic medical centres to private laboratories. Salary range in the United States is approximately $300,000–$450,000, influenced by geography, practice setting and subspecialty focus.
Cytopathology is the study of individual cells and small clusters of cells obtained from body fluids, smears and fine needle aspiration (FNA) biopsies. It provides rapid, minimally invasive diagnostic information that complements histopathological examination and, in many cases, can provide a definitive diagnosis without the need for surgical biopsy.
The major domains of cytopathology include cervical cytology (Pap smears) for cervical cancer screening, FNA biopsy of palpable and image-guided deep lesions (thyroid, lymph node, salivary gland, lung), and body fluid cytology (pleural, peritoneal, cerebrospinal fluid). Rapid on-site evaluation (ROSE) during FNA procedures is an increasingly important component of cytopathology practice.
In the United States, cytopathology fellowship is a 1-year programme after pathology residency. Board certification is available through the American Board of Pathology (ABP) Cytopathology subspecialty examination. In the UK, cytopathology training is integrated into the histopathology curriculum.
Digital cytology and AI-assisted screening are transforming the field, particularly in cervical cytology where automated screening systems are increasingly replacing manual primary screening. Liquid-based cytology has largely replaced conventional smears in high-resource settings, improving specimen quality and enabling ancillary molecular testing.
Dermatopathology is the microscopic examination and interpretation of skin biopsies. It stands uniquely at the intersection of two medical specialties: dermatology and pathology. Dermatopathologists diagnose a vast range of neoplastic, inflammatory and infectious conditions affecting the skin, hair and nails.
Dermatopathology is one of the few subspecialties that can be entered from either a pathology or a dermatology residency background. This dual-entry pathway reflects the subspecialty's position at the clinical-pathological interface and enriches the field with diverse perspectives.
Critical diagnostic areas include melanocytic lesions (distinguishing melanoma from benign naevi), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), inflammatory dermatoses (psoriasis, eczema, lichenoid reactions), vesiculobullous diseases, and cutaneous lymphoma. Melanoma diagnosis remains one of the most challenging and high-stakes areas in all of pathology.
Fellowship training is 1–2 years. Dermatopathology commands among the highest salaries in pathology, with US earnings typically ranging from $350,000 to $500,000 or more, particularly in private practice settings. The combination of high case volume, relative procedural simplicity and strong market demand drives this premium.
Neuropathology is the study of diseases of the nervous system, encompassing the brain, spinal cord, peripheral nerves and skeletal muscle. It is one of the most intellectually demanding pathology subspecialties, requiring deep knowledge of neuroanatomy, neuroscience and complex classification systems.
Major diagnostic domains include brain tumours (classified according to the WHO Classification of Tumours of the Central Nervous System, which now integrates molecular parameters), neurodegenerative diseases (Alzheimer's, Parkinson's, ALS, prion diseases), demyelinating conditions, epilepsy surgery specimens, and muscle and nerve biopsies. Neuropathologists also play a critical role in forensic and perinatal neuropathology.
Neuropathology fellowship is typically 2 years in the United States and leads to ABP board certification. The subspecialty is strongly research-oriented, with many neuropathologists holding dual clinical-research appointments. Academic positions predominate, though opportunities exist in large reference laboratories. Neuropathology is experiencing renewed interest due to the explosion of molecular diagnostics in neuro-oncology and the growing importance of neurodegenerative disease research.
Renal pathology focuses on the interpretation of kidney biopsies and is distinctive for requiring the integration of three complementary diagnostic modalities: light microscopy, immunofluorescence and electron microscopy. This triple assessment approach is unique in pathology and makes renal pathology one of the most technically demanding subspecialties.
The triple assessment involves light microscopic evaluation of H&E, PAS, silver and trichrome-stained sections; direct immunofluorescence for immunoglobulin and complement deposition patterns; and ultrastructural examination by electron microscopy to identify immune complex deposits, basement membrane abnormalities and podocyte changes. All three modalities are essential for accurate classification.
Major diagnostic entities include glomerulonephritis (IgA nephropathy, membranous nephropathy, ANCA-associated disease), transplant rejection (Banff classification), diabetic nephropathy, lupus nephritis, thrombotic microangiopathies and amyloidosis. Each requires integration of clinical, serological and pathological data for optimal diagnosis.
Fellowship training is typically 1 year. Renal pathologists are in steady demand at academic centres, transplant programmes and reference laboratories. Close collaboration with clinical nephrologists is a defining feature of the subspecialty.
Ophthalmic pathology is concerned with the examination of eye and ocular adnexal specimens, including enucleation specimens, orbital biopsies, eyelid lesions and conjunctival specimens. It is a rare and highly specialised subspecialty with relatively few dedicated training centres worldwide.
Key diagnostic areas include retinoblastoma, uveal melanoma, orbital lymphoma, corneal pathology and inflammatory conditions of the eye. Due to the small number of dedicated ophthalmic pathologists, many cases are referred to specialist centres. Practitioners typically work in academic settings with close ties to ophthalmology departments. The rarity of the subspecialty means that positions are limited but competition is correspondingly lower.
Pediatric pathology encompasses the diagnosis of diseases affecting fetuses, neonates, infants and children. It covers a distinctive spectrum of pathology that differs substantially from adult disease, including congenital anomalies, developmental disorders, childhood tumours and perinatal pathology.
Major diagnostic domains include placental pathology, congenital malformations, childhood solid tumours (Wilms tumour, neuroblastoma, rhabdomyosarcoma, hepatoblastoma), metabolic storage diseases, and perinatal/neonatal autopsy. Pediatric pathologists also contribute to prenatal diagnosis programmes and genetic counselling through examination of products of conception and stillbirth investigation.
Fellowship training is 1 year, leading to ABP board certification. Pediatric pathologists typically practise in children's hospitals or academic medical centres with paediatric services. The subspecialty offers a unique combination of diagnostic challenge and the satisfaction of contributing to the care of the youngest patients.
Gastrointestinal and hepatopathology covers the diagnostic pathology of the entire digestive tract (oesophagus to rectum), liver, gallbladder and pancreas. It is one of the highest-volume surgical pathology subspecialties, driven by the enormous number of endoscopic biopsies performed for screening, surveillance and diagnostic purposes.
Critical diagnostic entities include inflammatory bowel disease (Crohn's disease and ulcerative colitis), coeliac disease, Barrett's oesophagus and dysplasia surveillance, colorectal polyps and adenocarcinoma, hepatitis (viral, autoimmune, drug-induced), cirrhosis and hepatocellular carcinoma, and pancreatic neoplasms. The integration of molecular testing is increasingly important, particularly for colorectal cancer (microsatellite instability, RAS/BRAF status) and GI stromal tumours.
GI and hepatopathology offers excellent job prospects due to high case volume and consistent demand. Fellowship training is typically 1 year. Practitioners work across academic, hospital and private laboratory settings. The subspecialty requires strong familiarity with evolving classification systems and clinical management protocols.
Breast pathology involves the diagnostic examination of core biopsies, excision specimens and sentinel lymph nodes from the breast. It is a high-profile subspecialty with significant clinical impact, as pathological assessment directly determines treatment decisions including the need for chemotherapy, hormonal therapy and targeted biological agents.
Breast pathologists must be expert in the assessment of prognostic and predictive biomarkers: oestrogen receptor (ER), progesterone receptor (PR), HER2 (by IHC and in-situ hybridisation) and Ki-67 proliferation index. Accurate biomarker assessment is critical for treatment selection and is subject to rigorous quality assurance standards. Genomic assays (Oncotype DX, MammaPrint) are increasingly integrated into routine practice.
Breast pathology carries among the highest medico-legal scrutiny of any pathology subspecialty. Missed or delayed diagnoses of breast cancer, discordant biomarker results and classification errors in borderline lesions (atypical ductal hyperplasia vs. ductal carcinoma in situ) are common sources of litigation. Rigorous quality assurance, second-opinion programmes and clear documentation are essential.
Bone and soft tissue pathology deals with the diagnosis of neoplastic and non-neoplastic conditions of the musculoskeletal system, including sarcomas, benign tumours, metabolic bone disease and reactive conditions. It is a complex subspecialty with a large number of diagnostic entities and increasingly relies on molecular testing for accurate classification.
The WHO Classification of Soft Tissue and Bone Tumours recognises over 100 distinct entities, many of which are rare and morphologically overlapping. Molecular testing has become indispensable: characteristic translocations (e.g., EWSR1-FLI1 in Ewing sarcoma, SYT-SSX in synovial sarcoma), gene amplifications (MDM2 in dedifferentiated liposarcoma) and specific mutations guide diagnosis, particularly when morphology alone is ambiguous. FISH, RT-PCR and next-generation sequencing are routine ancillary tools.
Bone and soft tissue pathologists are relatively few in number and typically practise in academic centres or large reference laboratories with sarcoma expertise. Fellowship training is 1 year. The subspecialty offers high intellectual satisfaction due to diagnostic complexity, strong research opportunities and the chance to contribute to multidisciplinary sarcoma teams.
Clinical pathology (laboratory medicine) encompasses the disciplines that analyse blood, body fluids and other specimens using biochemical, immunological, microbiological and haematological methods. These subspecialties focus on laboratory-based diagnosis rather than tissue morphology.
Hematopathology is the study of diseases affecting the blood, bone marrow, lymph nodes and spleen. It bridges anatomical and clinical pathology, combining morphological assessment with advanced laboratory techniques to diagnose and classify haematological malignancies and non-neoplastic blood disorders.
Major diagnostic domains include acute and chronic leukaemias, lymphomas (Hodgkin and non-Hodgkin), myeloproliferative neoplasms, myelodysplastic syndromes, plasma cell neoplasms, coagulation disorders and anaemias. The WHO Classification of Haematolymphoid Tumours is the essential reference and integrates morphology, immunophenotype, cytogenetics and molecular genetics.
Hematopathologists employ a multimodal diagnostic approach: peripheral blood smear and bone marrow morphology, flow cytometry immunophenotyping, cytogenetics (karyotype, FISH), and molecular genetics (PCR, NGS). Integration of all these modalities is essential for accurate diagnosis and classification according to current WHO standards.
Fellowship training is 1–2 years, leading to ABP board certification. Hematopathologists are in strong demand across academic, hospital and reference laboratory settings. The subspecialty offers extensive research opportunities, particularly in the molecular characterisation of haematological malignancies and the development of targeted therapies.
Clinical chemistry (known as chemical pathology in the UK and many Commonwealth countries) is the laboratory analysis of blood, urine and other body fluids for the diagnosis and monitoring of disease. It is one of the largest laboratory disciplines by test volume and underpins much of modern medical practice.
Major domains include metabolic diseases (diabetes, lipid disorders, inborn errors of metabolism), endocrinology (thyroid, adrenal, pituitary function testing), toxicology and therapeutic drug monitoring, tumour markers, cardiac biomarkers, kidney and liver function testing, and point-of-care testing management. Chemical pathologists also play a key role in laboratory quality management, test utilisation and clinical consultation.
Modern clinical chemistry laboratories employ high-throughput automated analysers, liquid chromatography-tandem mass spectrometry (LC-MS/MS), immunoassay platforms and increasingly sophisticated informatics systems. The trend toward automation, consolidation and total laboratory automation (TLA) is reshaping laboratory design and workflow.
In the UK, chemical pathology is a standalone specialty with FRCPath certification. In the US, clinical chemistry falls under Clinical Pathology (CP) board certification, with additional fellowship training available through AACC-accredited programmes. The subspecialty offers a distinctive career combining laboratory expertise with clinical consultation.
Medical microbiology is the identification and characterisation of infectious agents causing human disease. It encompasses bacteriology, virology, mycology and parasitology, and plays a central role in infection diagnosis, antimicrobial stewardship and public health response to outbreaks and pandemics.
Core activities include culture-based identification of bacteria and fungi, antimicrobial susceptibility testing, serological and molecular diagnosis of viral infections, parasitology, infection prevention and control, and antimicrobial stewardship programmes. Clinical microbiologists provide real-time consultation on the selection and optimisation of antimicrobial therapy.
Molecular methods have transformed microbiology practice. PCR-based syndromic panels enable rapid identification of multiple pathogens from a single specimen, while MALDI-TOF mass spectrometry has revolutionised organism identification from colonies. Whole-genome sequencing is increasingly used for outbreak investigation and resistance gene detection. These advances have dramatically reduced time to diagnosis and improved patient outcomes.
In the UK, medical microbiology and virology are distinct FRCPath specialties. In the US, clinical microbiology fellowship follows Clinical Pathology residency. The COVID-19 pandemic has underscored the critical importance of this subspecialty and driven significant investment in laboratory capacity and workforce development.
Immunology (immunopathology) deals with the laboratory diagnosis and monitoring of immune-mediated diseases, including autoimmune conditions, primary and secondary immunodeficiency, allergic diseases and transplant immunology. Clinical immunologists bridge laboratory science and clinical medicine, often providing direct patient care alongside laboratory oversight.
Major diagnostic domains include autoimmune disease serology (ANA, anti-dsDNA, ANCA, anti-CCP), immunodeficiency evaluation (immunoglobulin levels, lymphocyte subsets, functional assays), complement studies, HLA typing for transplantation, and allergy testing. Key laboratory techniques include ELISA, fluorescent immunoassay, flow cytometry, nephelometry, and increasingly multiplex bead-based assays and molecular HLA typing.
Transplant immunology is a critical area encompassing pre-transplant crossmatching, donor-specific antibody monitoring and post-transplant immune surveillance. The development of solid-phase assays (Luminex) has transformed the sensitivity and specificity of antibody detection in transplantation.
Transfusion medicine encompasses blood group serology, blood component therapy, apheresis, and patient blood management. Transfusion medicine specialists ensure the safe and effective use of blood products, manage complex serological problems, and lead patient blood management programmes aimed at reducing unnecessary transfusion.
Core activities include ABO/Rh typing and antibody identification, compatibility testing, management of transfusion reactions, therapeutic apheresis (plasmapheresis, leukapheresis), haematopoietic progenitor cell collection and processing, and oversight of hospital transfusion committees. Patient blood management — a multidisciplinary, evidence-based approach to optimising patient outcomes by minimising blood loss and managing anaemia — is an increasingly important focus.
Fellowship training is 1 year in the US (Blood Banking/Transfusion Medicine, ABP-certified). Transfusion medicine specialists work in hospital blood banks, regional blood centres and national blood services. The subspecialty offers a unique combination of laboratory expertise, clinical consultation and quality/safety management.
The fastest-growing and most transformative areas of pathology. These subspecialties are reshaping how disease is diagnosed, classified and treated, and offer some of the most dynamic career opportunities in the field.
Molecular pathology is the genetic and molecular analysis of disease at the DNA, RNA and protein level. It has become indispensable to modern pathology practice, driving the precision medicine revolution by identifying actionable therapeutic targets, detecting minimal residual disease and enabling non-invasive liquid biopsy diagnostics.
The molecular pathology toolkit includes next-generation sequencing (NGS) for targeted panels and whole-exome/genome sequencing, polymerase chain reaction (PCR) and quantitative PCR, fluorescence in-situ hybridisation (FISH), gene expression profiling, methylation analysis, and microsatellite instability testing. Bioinformatics expertise is increasingly essential for variant interpretation and clinical reporting.
Key clinical applications include targeted therapy selection in oncology (e.g., EGFR mutations in lung cancer, BRAF in melanoma), companion diagnostics, liquid biopsy for circulating tumour DNA (ctDNA), pharmacogenomics, hereditary cancer syndrome testing, and minimal residual disease monitoring in haematological malignancies. The scope of molecular pathology continues to expand into infectious disease, transplant medicine and prenatal diagnostics.
Molecular Genetic Pathology (MGP) fellowship is typically 1–2 years and is jointly accredited by pathology and medical genetics boards. Molecular pathology is currently the most in-demand subspecialty for fellowship training, driven by the exponential growth of precision oncology and genomic medicine. Career opportunities exist across academic centres, reference laboratories, pharmaceutical companies and biotechnology firms.
Digital pathology involves the digitisation of glass histology slides using whole slide imaging (WSI) scanners, enabling remote viewing, computational image analysis and AI-assisted diagnosis. It represents a paradigm shift in how pathology is practised, moving from the traditional microscope to digital workflows that enable new capabilities impossible with glass slides alone.
New career roles are emerging within digital pathology: digital pathology lead (overseeing implementation and validation of digital workflows), AI validation pathologist (evaluating and validating AI algorithms for clinical deployment), computational pathologist (developing image analysis algorithms and AI models), and digital pathology informatics specialist (managing PACS, LIS integration and data governance).
Proficiency in whole slide imaging technology, image analysis software, AI and machine learning fundamentals, laboratory informatics (PACS, LIS), data governance, and regulatory frameworks (FDA, CE-IVDR) for digital pathology and AI devices. Programming skills (Python, R) are increasingly valued, particularly for computational pathology roles.
Digital pathology is not yet a formal fellowship or board-certified subspecialty in most countries, though dedicated training programmes and certificates are emerging. Pathologists with demonstrated digital and AI expertise command a salary premium of approximately 15–25% above comparable roles without these skills, reflecting strong market demand for this expertise.
Forensic pathology is the determination of cause and manner of death in cases of sudden, unexpected, suspicious or violent death. Forensic pathologists perform medicolegal autopsies, examine death scenes, interpret toxicology results and provide expert testimony in court proceedings. It is a unique subspecialty that bridges medicine and the legal system.
The forensic pathologist's work includes complete medicolegal autopsy with external and internal examination, scene investigation (attending death scenes to assess circumstances), interpretation of injury patterns (blunt force, sharp force, gunshot, asphyxia), toxicological correlation, certification of cause and manner of death, and expert witness testimony in criminal and civil proceedings.
In the United States, forensic pathology fellowship is 1 year following pathology residency, leading to ABP board certification. In some countries (UK, Australia), forensic pathology is a standalone specialty training pathway. The subspecialty has a well-documented workforce shortage in many jurisdictions, creating strong job opportunities.
Forensic pathologists work in medical examiner offices, coroner services, academic departments and some military settings. The lifestyle is distinctive: on-call responsibilities for scene attendance (often nights and weekends), exposure to emotionally challenging cases, and regular court appearances. Despite these demands, many forensic pathologists find the work deeply rewarding for its contribution to justice and public safety.
A structured framework to help pathology trainees and early-career pathologists identify the subspecialty that best aligns with their skills, interests and career goals.
Do you prefer high-throughput sign-out (GI, breast) or fewer, intellectually complex cases (neuropathology, bone & soft tissue)? Understanding your comfort with pace versus depth is fundamental to subspecialty satisfaction.
Patient interaction ranges from minimal (clinical chemistry, surgical pathology) to variable (forensic — families, legal teams) to moderate (FNA cytopathology, transfusion medicine consultation). Consider your preferences carefully.
If academic research is a priority, neuropathology, molecular pathology, hematopathology and digital pathology offer the richest research environments. Consider NIH funding trends and industry collaboration potential.
Dermatopathology and clinical chemistry generally offer predictable hours. Forensic pathology involves on-call and scene visits. Surgical pathology volume can create time pressure. Evaluate your lifestyle priorities honestly.
Dermatopathology and surgical pathology (private practice) tend toward the highest compensation. Forensic pathology and academic neuropathology are typically at the lower end. Consider total compensation including benefits and pension.
Molecular pathology, GI pathology, hematopathology and forensic pathology currently have the strongest job markets. Ophthalmic pathology and neuropathology positions are fewer but less competitive. Monitor trends through CAP and ASCP workforce data.
If you are excited by emerging technology, digital pathology, molecular pathology and computational pathology are at the innovation frontier. Consider whether you want to be an early adopter or prefer established practice patterns.
Some subspecialties are concentrated in major academic centres (neuropathology, ophthalmic pathology), while others offer broad geographic flexibility (surgical pathology, dermatopathology). International practice varies significantly by subspecialty recognition.
All 18 pathology subspecialties compared across key career decision factors.
| Subspecialty | Fellowship | Board Cert. | Job Demand | Salary Range (US) | Research | Patient Contact | AI Impact | Work-Life |
|---|---|---|---|---|---|---|---|---|
| Surgical Pathology | Core | ABP AP | Very High | $300K–$450K | Medium | Low | High | Good |
| Cytopathology | 1 year | ABP Cyto | High | $300K–$425K | Medium | Moderate | High | Good |
| Dermatopathology | 1–2 years | ABP/ABD | High | $350K–$500K+ | Medium | Low | Medium | Very Good |
| Neuropathology | 2 years | ABP Neuro | Low | $275K–$375K | Very High | Low | High | Good |
| Renal Pathology | 1 year | ABP | Medium | $300K–$400K | High | Low | Low | Good |
| Ophthalmic Pathology | 1 year | ABP | Low | $275K–$375K | Medium | Low | Low | Very Good |
| Pediatric Pathology | 1 year | ABP Peds | Medium | $275K–$375K | Medium | Low | Low | Good |
| GI & Hepatopathology | 1 year | ABP | Very High | $325K–$450K | Medium | Low | Medium | Fair |
| Breast Pathology | 1 year | ABP | High | $300K–$425K | Medium | Low | High | Good |
| Bone & Soft Tissue | 1 year | ABP | Medium | $300K–$400K | High | Low | Medium | Good |
| Hematopathology | 1–2 years | ABP Heme | High | $300K–$425K | Very High | Low | Medium | Good |
| Clinical Chemistry | 1–2 years | ABP CP / FRCPath | Medium | $275K–$400K | Medium | Low | Medium | Very Good |
| Medical Microbiology | 1 year | ABP / FRCPath | High | $275K–$400K | High | Moderate | Medium | Fair |
| Immunology | 1–2 years | ABP / FRCPath | Medium | $275K–$375K | High | Moderate | Low | Good |
| Transfusion Medicine | 1 year | ABP BB/TM | Medium | $275K–$375K | Medium | Moderate | Low | Good |
| Molecular Pathology | 1–2 years | ABP MGP | Very High | $300K–$450K | Very High | Low | Very High | Good |
| Digital Pathology | Emerging | None (yet) | Very High | +15–25% premium | Very High | Low | Very High | Good |
| Forensic Pathology | 1 year | ABP Forensic | High | $250K–$375K | Low | Variable | Low | Fair |
Continue exploring pathology careers, training and opportunities with these comprehensive guides.
Step-by-step career guide covering medical school, residency, fellowship and beyond. Everything you need to plan your path into pathology.
Complete guide to board certifications worldwide: ABP, FRCPath, FRCPA and international equivalency. Requirements, timelines and preparation resources.
Search current pathology vacancies worldwide. Filter by subspecialty, location, seniority and practice setting to find your ideal position.
Comprehensive salary data by subspecialty, country, experience level and practice setting. Compensation benchmarks and negotiation guidance.
Courses, webinars, workshops and continuing professional development resources across all pathology subspecialties.
Explore every pathology specialization with curated articles, clinical cases, diagnostic guides, leading professionals and career opportunities.